Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 59, 2004 - Issue 4
17
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

GRAFT-VERSUS-HOST DISEASE : REVIEW OF 22 CASES

, , , , , & show all
Pages 182-188 | Published online: 09 Jan 2014
 

Abstract

Purpose: Graft-versus-host disease (GVHD) is one of the major complications of allogeneic bone marrow transplantation. Twenty-two patients, who had an allogeneic bone marrow transplantion at the Institute J. Bordet, developed a GVHD proven by a biopsy.

Results: Twenty-two cases of GVHD were registered; 17 of these patients suffered from the acute form of the disease. All the patients presented the characteristic skin lesions, usualy associated with other organ involvement. Most of the cases suffered from relapse after a timelimited response or from resistance to therapy, despite an effective treatment. Uncontrolled GVHD led to the death of two patients.

Conclusion: GVHD is a frequent pathology that signifi cantly contributes to the morbidity and mortality associated with bone marrow transplantation, despite appropriate management. Recognition of clinical and histopathological features of GVHD is important for dermatologists involved in the care of bone marrow transplant patients. Actually, bone marrow transplantation is now easily and more frequently performed than in the past.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.